VivoSim Labs, INC.(VIVS)— Stock Profile, AI Score & Financials
Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
VivoSim Labs, INC. (VIVS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores VIVS at 21.3/100 on a 32-signal composite quality model, placing it at rank #2,768 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), VivoSim Labs, INC. reports quarterly revenue of $18.0K, net income of $-1.3M, free cash flow of $-3.2M. Top institutional holders of VIVS by reported 13-F value include GEODE CAPITAL MANAGEMENT, RENAISSANCE TECHNOLOGIES, HRT FINANCIAL, based on the most recent SEC filings. VIVS trades on the Nasdaq exchange and files with the SEC under CIK 1497253. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate VIVS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for VivoSim Labs, INC. directly from SEC EDGAR.
AI Quality Score
21.3/100
AI Rank
#2,768
Revenue
$18.0K
Net Income
$-1.3M
Free Cash Flow
$-3.2M
VIVS key financials by period
VivoSim Labs, INC. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2026
10-K
$131.0K
$-13.8M
—
FY 2025
10-K
$144.0K
$-2.5M
—
FY 2024
10-K
$109.0K
$-14.7M
—
FY 2023
10-K
$370.0K
$-17.3M
—
FY 2022
10-K
$1.5M
$-11.4M
—
FY 2020
10-K
$2.2M
$-18.7M
—
Institutions holding VIVS
Institutional investors reporting a position in VivoSim Labs, INC. on SEC Form 13F.
